Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN PHARMACEUTICALS vs HINDUSTAN BIOSCIE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN PHARMACEUTICALS HINDUSTAN BIOSCIE SUVEN PHARMACEUTICALS/
HINDUSTAN BIOSCIE
 
P/E (TTM) x 46.4 265.4 17.5% View Chart
P/BV x 9.9 10.0 99.7% View Chart
Dividend Yield % 0.9 0.0 -  

Financials

 SUVEN PHARMACEUTICALS   HINDUSTAN BIOSCIE
EQUITY SHARE DATA
    SUVEN PHARMACEUTICALS
Mar-23
HINDUSTAN BIOSCIE
Mar-23
SUVEN PHARMACEUTICALS/
HINDUSTAN BIOSCIE
5-Yr Chart
Click to enlarge
High Rs6296 11,233.9%   
Low Rs3883 11,996.9%   
Sales per share (Unadj.) Rs52.70.9 5,853.3%  
Earnings per share (Unadj.) Rs16.20 -41,400.4%  
Cash flow per share (Unadj.) Rs18.00 -52,806.0%  
Dividends per share (Unadj.) Rs6.000-  
Avg Dividend yield %1.20-  
Book value per share (Unadj.) Rs68.20.7 9,352.8%  
Shares outstanding (eoy) m254.5710.25 2,483.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x9.74.9 196.7%   
Avg P/E ratio x31.5-111.7 -28.2%  
P/CF ratio (eoy) x28.2-130.2 -21.6%  
Price / Book Value ratio x7.56.1 123.0%  
Dividend payout %37.10-   
Avg Mkt Cap Rs m129,39545 285,909.3%   
No. of employees `000NANA-   
Total wages/salary Rs m1,1052 61,738.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m13,4039 145,371.9%  
Other income Rs m4640-   
Total revenues Rs m13,8679 150,400.5%   
Gross profit Rs m5,7390 -2,049,675.0%  
Depreciation Rs m4770 795,533.3%   
Interest Rs m1280 320,275.0%   
Profit before tax Rs m5,5970 -1,472,973.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,4840 4,948,000.0%   
Profit after tax Rs m4,1130 -1,028,225.0%  
Gross profit margin %42.8-3.1 -1,400.5%  
Effective tax rate %26.5-6.6 -403.1%   
Net profit margin %30.7-4.4 -699.4%  
BALANCE SHEET DATA
Current assets Rs m11,5549 134,345.0%   
Current liabilities Rs m3,03114 21,374.3%   
Net working cap to sales %63.6-60.6 -105.0%  
Current ratio x3.80.6 628.5%  
Inventory Days Days148946 15.7%  
Debtors Days Days302179,564,165 0.0%  
Net fixed assets Rs m9,54724 39,385.2%   
Share capital Rs m25521 1,241.8%   
"Free" reserves Rs m17,097-13 -131,114.1%   
Net worth Rs m17,3527 232,287.0%   
Long term debt Rs m4611 406.8%   
Total assets Rs m21,10133 64,252.9%  
Interest coverage x44.7-8.5 -525.8%   
Debt to equity ratio x01.5 0.2%  
Sales to assets ratio x0.60.3 226.2%   
Return on assets %20.1-1.1 -1,815.8%  
Return on equity %23.7-5.4 -437.7%  
Return on capital %32.9-1.8 -1,817.1%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m14,6726 249,947.2%   
Fx outflow Rs m1,8480-   
Net fx Rs m12,8246 218,470.2%   
CASH FLOW
From Operations Rs m4,509-1 -901,824.0%  
From Investments Rs m-1,948NA-  
From Financial Activity Rs m-2,3581 -471,662.0%  
Net Cashflow Rs m2020-  

Share Holding

Indian Promoters % 9.9 12.2 81.2%  
Foreign collaborators % 50.1 0.0 -  
Indian inst/Mut Fund % 26.1 0.0 -  
FIIs % 10.1 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 40.0 87.8 45.6%  
Shareholders   70,052 10,315 679.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN PHARMACEUTICALS With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on SUVEN PHARMACEUTICALS vs HINDUSTAN BIOSCIE

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

SUVEN PHARMACEUTICALS vs HINDUSTAN BIOSCIE Share Price Performance

Period SUVEN PHARMACEUTICALS HINDUSTAN BIOSCIE S&P BSE HEALTHCARE
1-Day 5.78% -1.89% 1.18%
1-Month 5.21% -24.16% -0.75%
1-Year 44.00% -13.38% 61.82%
3-Year CAGR 12.19% 34.35% 18.16%
5-Year CAGR 32.13% 50.47% 19.79%

* Compound Annual Growth Rate

Here are more details on the SUVEN PHARMACEUTICALS share price and the HINDUSTAN BIOSCIE share price.

Moving on to shareholding structures...

The promoters of SUVEN PHARMACEUTICALS hold a 60.0% stake in the company. In case of HINDUSTAN BIOSCIE the stake stands at 12.2%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of SUVEN PHARMACEUTICALS and the shareholding pattern of HINDUSTAN BIOSCIE.

Finally, a word on dividends...

In the most recent financial year, SUVEN PHARMACEUTICALS paid a dividend of Rs 6.0 per share. This amounted to a Dividend Payout ratio of 37.1%.

HINDUSTAN BIOSCIE paid Rs 0.0, and its dividend payout ratio stood at -0.0%.

You may visit here to review the dividend history of SUVEN PHARMACEUTICALS, and the dividend history of HINDUSTAN BIOSCIE.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.